Form 4: Pulmonx Corp Executive Rose Geoffrey Beran Sells Shares
SEC Form 4 Filing
Chief Commercial Officer of Pulmonx Corp, Rose Geoffrey Beran, sold 1,184 shares of common stock on June 24, 2024, at a price of $6.16 per share.
Summary
- On June 24, 2024, Rose Geoffrey Beran, Chief Commercial Officer of Pulmonx Corp, sold 1,184 shares of common stock.
- The sale was executed at a price of $6.16 per share.
- Following the transaction, Beran directly owns 300,019 shares of Pulmonx Corp.
- The sale was conducted under a Rule 10b5-1 trading plan adopted on May 24, 2023.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting an insider stock sale. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.
Industry Context
Insider sales are common and can be for various reasons, including diversification or personal financial planning. It's important to consider the overall trend of insider transactions and the company's performance when evaluating the significance of this sale.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by some shareholders, potentially leading to a slight decrease in investor confidence.
Key Dates
| Date | Description |
|---|---|
| May 24, 2023 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| June 24, 2024 | Date of the stock sale transaction |
| June 26, 2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.